Polsinelli Podcasts - Confusion to Clarity on the Future of the 340B Program
On 31 May 2022, the Italian Competition Authority (ICA) published its decision sanctioning the pharmaceutical company Leadiant EUR3.5 million for charging excessive prices for the sale of an orphan drug....more